www.monahancenter.org
www.cancer.org
Current Projects
PanCan New York Scientific Symposium on Pancreatic Cancer, June 23, 2007
Slide show presented by Dr. Felice Schnoll-Sussman, Linda Horowitz Cancer Research Foundation Clinical Scholar, presented to pancreatic cancer survivors, their families and other advocates.
Click here to view
New York Scientific Symposium on Colorectal Cancer, March 2, 2007
Faculty member Dr. Felice Schnoll-Sussman, Linda Horowitz Cancer Research Clinical Scholar, Jay Monahan Center.
Click here to view
The Jay Monahan Center for Gastrointestinal Health at New York-Presbyterian Hospital/Weill Cornell Medical Center
The Jay Monahan Center for Gastrointestinal Health is a world-class gastrointestinal cancer and wellness center. The Monahan Center was founded in March 2004 in memory of attorney Jay Monahan, in large part, through the efforts of his wife, Katie Couric, and the organization she co-founded, the Entertainment Industry Foundation's National Colorectal Cancer Research Alliance. The Monahan Center serves as a unique model of coordinated and compassionate care, dedicated to public education and the prevention, diagnosis, treatment, and research of gastrointestinal cancers, including cancers of the colon, rectum, pancreas, esophagus, liver, gallbladder, stomach, and small intestine. For more information on the Monahan Center, visit www.monahancenter.org.
Felice Schnoll-Sussman, MD Linda Horowitz Cancer Research Foundation Clinical Scholar at The Jay Monahan Center for Gastrointestinal Health
Pancreatic cancer alone is the fourth-leading cause of cancer death in the United States, yet far too few resources are dedicated to the research and early treatment of this devastating disease. The Linda Horowitz Cancer Research Foundation Clinical Scholar Award, established in December 2005, was awarded to Felice Schnoll-Sussman, MD, gastroenterologist at The Jay Monahan Center for Gastrointestinal Health. The Linda Horowitz Cancer Research Foundation Clinical Scholar Award is providing Dr. Schnoll with the support needed to advance important areas of research in pancreatic cancer and other gastrointestinal cancer prevention and treatment.
Examples of Dr. Schnoll's current research projects include:
- Prevention of potential progression to pancreatic cancer:
Evaluation of the use of alcohol ablation in the treatment of mucinous cysts of the pancreas. These pancreatic cysts have the potential to progress to pancreatic cancer if not treated.
- Understanding the biology of pancreatic cysts:
Evaluation of biologic pathways, for example COX-2 pathways, in mucinous cysts of the pancreas, which have the potential to progress to pancreatic cancer.
- Investigation of the hereditary and familial components of pancreatic cancer:
- Evaluation of DNA from patients with pancreatic cancer and their family members to identify potentially inherited genetic mutations that may contribute to the development of pancreatic cancer.
- Evaluation of the role of MRCP and EUS procedures as screening tools in the early detection of pancreatic cancer in unaffected individuals with a family history of this disease.
- Prevention of potential progression to esophageal cancer:
Evaluation of green tree extract as chemoprophylaxis in patients with Barrett's esophagus, a pre-cancerous condition that significantly increases the risk of esophageal cancer.
It is hoped that the promising research being performed by Dr. Schnoll will ultimately lead to lifesaving advances in patient care--not only in the treatment of gastrointestinal cancers, but also in the prevention of these devastating diseases.
|
